CRNXCrinetics Pharmaceuticals, Inc.

$34.99

Is it safe?

Can CRNX take a bad year?

The deepest fall in CRNX's price history on file is −69%; it is 0.00% below its high today.

14.26

Altman Z-score · distress below 1.8 · safe above 3 · safe zone, the balance sheet is not what threatens this one

Cash runway
2.8 years

Cash runway · burning $106M a quarter at the current rate

Annualised volatility
112%

Annualised volatility · three times the market's own swing

Worst drawdown on file
−69%

Worst drawdown on file · 0.00% today

Details
Cash and short-term investments
$1.21B
EBITDA, trailing twelve months
−$545M
Operating profit, trailing twelve months
−$549M
Annualised volatilitytwo years of daily moves
112%
Worst drawdown on file
−69%
Below its 52-week high
0.00%

Balance sheet from SEC filings; drawdown and volatility from end-of-day closes; Altman Z from the filed statements.